N@N

Market Maker Surveillance Report. ISIS, SALM, OCLR, FTEK, OCLS, SNTA, Losing Stocks With Lowest Price Friction For Wednesday,

May 8, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3804 companies with "abnormal" market making, 3315 companies with positive Friction Factors and 2086 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS), Salem Communications Corp (NASDAQ:SALM), Oclaro Inc (NASDAQ:OCLR), Fuel Tech Inc (NASDAQ:FTEK), Oculus Innovative Sciences Inc (NASDAQ:OCLS), Synta Pharmaceuticals Corp (NASDAQ:SNTA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  ISIS    $-2.240   -10.22%   1,478,203    47.10%    1,649,119    52.54%    -170,916     -763    
  SALM    $-1.030   -11.44%   70,349       33.29%    141,002      66.71%    -70,653      -686    
  OCLR    $-0.270   -19.85%   3,525,989    43.84%    4,506,330    56.03%    -980,341     -36,309 
  FTEK    $-0.420   -10.50%   205,777      37.09%    341,021      61.46%    -135,244     -3,220  
  OCLS    $-0.800   -16.00%   211,314      38.36%    327,659      59.47%    -116,345     -1,454  
  SNTA    $-1.060   -13.38%   1,469,842    46.53%    1,669,878    52.86%    -200,036     -1,887  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ISIS with a dollar loss Wednesday of $-2.24000 and a Friction Factor of -763 shares. That means that it only took 763 more shares of selling than buying to move ISIS lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

ISIS PHARMACEUTICALS INCORPORATED (NASDAQ:ISIS) - Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using antisense drug discovery platform. Its product pipeline comprises 26 drugs to primarily treat cardiovascular, metabolic, severe, and rare diseases, as well as cancer. The company s flagship product, KYNAMRO, is an apo-B synthesis inhibitor in development for the reduction of low-density lipoprotein cholesterol. The company has collaboration agreements with Biogen Idec to develop and commercialize ISIS-SMNRx for the treatment of spinal muscular atrophy; Bristol-Myers Squibb to discover, develop, and commercialize antisense drugs targeting proprotein convertase subtilisin/kexin type 9; and Ortho-McNeil-Janssen Pharmaceuticals, Inc. to discover, develop, and commercialize antisense drugs to treat metabolic diseases, including type 2 diabetes. It also has a strategic relationship with Eli Lilly and Company for the development of LY2181308, an antisense inhibitor of survivin; and a strategic alliance with GlaxoSmithKline to develop new drugs against targets for rare and serious diseases, as well as with AstraZeneca PLC for the discovery and development of novel generation antisense therapeutics. The company was founded in 1989 and is headquartered in Carlsbad, California..

Salem Communications Corp (NASDAQ:SALM) - Salem Communications Corporation, a multi-media company, develops programs for audiences interested in Christian and conservative opinion content. The company owns and operates radio stations in metropolitan markets; and radio networks that produce and distribute programming, such as talk, news, and music segments to radio stations in the United States, as well as sell commercial airtime to national advertisers on its radio stations and networks, and on independent radio station affiliates. Salem Communications Corporation programs its radio stations in various formats, including Christian teaching and talk, block programming, news talk, contemporary Christian music, Spanish Christian teaching and talk, and business. The company also owns and operates Internet portals, including OnePlace.com, Christianity.com, Crosswalk.com, BibleStudyTools.com, GodTube.com, Townhall.com, HotAir.com, WorshipHouse Media.com, and Jesus.org that provide Christian and conservative themed content, audio and video streaming, and other resources on the Web; and radio station Websites, as well as Salem Consumer Products, a Website that offers books, DVDs, and editorial content. In addition, it produces and distributes Christian and conservative opinion print magazines, including Homecoming The Magazine, YouthWorker Journal, Singing News, FaithTalk Magazine, and Preaching and Townhall Magazine, as well as Xulon Press, a print-on-demand self-publishing service for Christian authors. The company primarily serves not-for-profit charitable organizations and commercial advertisers. Salem Communications Corporation was founded in 1986 and is headquartered in Camarillo, California..

Oclaro Inc (NASDAQ:OCLR) - Oclaro, Inc. provides optical communications and laser components, modules, and subsystems for telecommunications, industrial, scientific, consumer electronics, and medical markets worldwide. It designs, manufactures, and markets products that generate, detect, amplify, combine, and separate light signals in telecommunications networks. The company offers tunable laser transmitters and fixed wavelength laser transmitters, which include discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; discrete receivers for metro and long-haul applications; small form factor pluggable transceivers; and transponder modules that provide transmitter and receiver functions. Its products also comprise amplifiers for brightness of optical signals, and compact amplification of ultra long-haul, long-haul, and metro networks; pump laser chips for use as high-power pump sources for amplifiers in terrestrial and undersea, or submarine applications; wavelength management products, such as switching and routing solutions, multiplexing and signal processing solutions, and micro-optics and integrated modules. In addition, the company offers tunable dispersion compensation products to compensate for chromatic dispersion and dispersion degradation of transmission signals; thin film filters for multiplexing and demultiplexing optical signals within dense wave division multiplexing transmission systems; pump laser technology diodes for material processing, medical, cosmetic, 3-D imaging, and printing applications; and vertical cavity surface emitting laser products for optical mouse and finger navigation applications. Oclaro, Inc. markets its products through direct sales and marketing organization, sales representatives, and resellers. The company was formerly known as Bookham Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California..

Fuel Tech Inc (NASDAQ:FTEK) - Fuel Tech, Inc. provides engineered solutions for the optimization of combustion systems in utility and industrial applications worldwide. The company offers air pollution control technologies, such as low and ultra low nitrogen oxide (NOx) burners, over-fire air systems, NOxOUT and HERT selective non-catalytic reduction systems, and advanced selective catalytic reduction systems to reduce NOx emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources. It also provides ULTRA technology, which converts urea-to-ammonia on site offering safe reagent for use in selective catalytic reduction systems; and flue gas conditioning systems that are chemical injection systems used to enhance electrostatic precipitator and fabric filter performance in controlling particulate emissions. In addition, the company offers FUEL CHEM technologies, which control slagging, fouling, corrosion, opacity, and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using Targeted In-Furnace Injection technology. Fuel Tech, Inc. offers its FUEL CHEM program for plants operating in the electric utility, industrial, pulp and paper, waste-to-energy, university, and district heating markets, as well as to the owners of boilers, furnaces, and other combustion units. The company sells its products through its direct sales force and agents. Fuel Tech, Inc. was founded in 1987 and is headquartered in Warrenville, Illinois..

Oculus Innovative Sciences Inc (NASDAQ:OCLS) - Oculus Innovative Sciences, Inc. designs, produces, and markets drugs, devices, and nutritional products based on its Microcyn platform technology for the dermatology, surgical, wound care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. Microcyn platform technology is based on electrically charged oxychlorine small molecules that target a range of disease causing organisms, which include viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in wounds, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human wound and skin care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand name. The company also offers Glucorein Green Tea with chlorogenic acid, a medical food for the dietary management of glucose levels in pre-diabetics and type 2 diabetics. Its Microcyn has received seven 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, the company provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. It sells its products to hospitals, physicians, nurses, and other healthcare practitioners who are the primary caregivers to patients being treated for acute or chronic wounds or undergoing surgical procedures, as well as to dermatologists for the treatment of various skin afflictions. Oculus sells its products directly, as well as through contract sales organization and distributors. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is based in Petaluma, California..

Synta Pharmaceuticals Corp (NASDAQ:SNTA) - Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug candidates in clinical trials for treating multiple types of cancer and various drug candidates in the preclinical stage of development. Its oncology product portfolio includes Ganetespib, an Hsp90 inhibitor in phase 2b/3 clinical trial for various types of cancers, including non-small cell lung cancer, anaplastic lymphoma kinase, breast cancer, gastric cancer, prostate cancer, colon cancer, pancreatic cancer, multiple myeloma, acute myeloid leukemia, rectal cancer, ocular melanoma, melanoma, and hepatocellular cancer; Elesclomol, a mitochondria-targeting agent in phase 2 clinical trails for ovarian cancer and phase 1 clinical trial for acute myeloid leukemia; STA-9584, a vascular disrupting agent in preclinical development stage for prostate cancer; and various Hsp90 inhibitors in preclinical development stage for cancers. The company s inflammatory diseases product portfolio includes CRACM ion channel inhibitors in preclinical development stage for autoimmune diseases, respiratory conditions, and transplantation; and IL-12/23 inhibitors in lead optimization stage for autoimmune diseases. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---